Carna Biosciences Inc (4572)

Tokyo
Currency in JPY
279.0
+5.0(+1.82%)
Closed·
4572 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4572 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
269.0279.0
52 wk Range
220.0482.0
Key Statistics
Edit
Bid/Ask
275.00 / 279.00
Prev. Close
274
Open
275
Day's Range
269-279
52 wk Range
220-482
Volume
26.9K
Average Volume (3m)
108.75K
1-Year Change
-36.01%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4572 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
No news in this category
Looks like there are no results in this news category

Carna Biosciences Company Profile

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, Luciferase PPI stable cell lines, kinase assay kits, peptide substrate, mobility shifty assay, and lipid kinase panels. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection assays. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Sumitomo Pharma, Gilead Sciences. Carna Biosciences, Inc. was incorporated in 2003 and is based in Kobe, Japan.

Compare 4572 to Peers and Sector

Metrics to compare
4572
Peers
Sector
Relationship
P/E Ratio
−2.3x−0.3x−0.5x
PEG Ratio
0.020.000.00
Price/Book
2.7x1.4x2.6x
Price / LTM Sales
8.9x1.7x3.0x
Upside (Analyst Target)
-84.7%53.7%
Fair Value Upside
Unlock27.8%8.4%Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-26.13 / --
Revenue / Forecast
143.00M / --
EPS Revisions
Last 90 days

FAQ

What Is the Carna Biosciences (4572) Stock Price Today?

The Carna Biosciences stock price today is 279.00.

What Stock Exchange Does Carna Biosciences Trade On?

Carna Biosciences is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Carna Biosciences?

The stock symbol for Carna Biosciences is "4572."

What Is the Carna Biosciences Market Cap?

As of today, Carna Biosciences market cap is 5.33B.

What Is Carna Biosciences's Earnings Per Share (TTM)?

The Carna Biosciences EPS (TTM) is -123.87.

When Is the Next Carna Biosciences Earnings Date?

Carna Biosciences will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is 4572 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.